文献
J-GLOBAL ID:201002266303094019
整理番号:10A0296126
転移腎細胞癌の日本人患者に対するスニチニブの第二相試験:治療,有効性,安全性についての考察
A Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma: Insights into the Treatment, Efficacy and Safety
著者 (15件):
UEMURA Hirotsugu
(Kinki Univ. School of Medicine, Osaka)
,
SHINOHARA Nobuo
(Hokkaido Univ. Graduate School of Medicine, Sapporo)
,
YUASA Takeshi
(Akita Univ. School of Medicine, Akita)
,
TOMITA Yoshihiko
(Yamagata Univ. School of Medicine, Yamagata)
,
FUJIMOTO Hiroyuki
(National Cancer Center Hospital, Tokyo)
,
NIWAKAWA Masashi
(Shizuoka Cancer Center Hospital, Shizuoka)
,
MUGIYA Soichi
(Hamamatsu Univ. School of Medicine, Hamamatsu)
,
MIKI Tsuneharu
(Kyoto Prefectural Univ. Medicine, Kyoto)
,
NONOMURA Norio
(Osaka Univ. Graduate School of Medicine, Osaka)
,
TAKAHASHI Masayuki
(Univ. Tokushima Graduate School, Tokushima)
,
HASEGAWA Yoshihiro
(National Kyushu Cancer Center Hospital, Fukuoka)
,
AGATA Naoki
(Pfizer Japan Inc, Tokyo, JPN)
,
HOUK Brett
(Pfizer Global Res. and Dev., La Jolla, USA)
,
NAITO Seiji
(Kyushu Univ., Fukuoka)
,
AKAZA Hideyuki
(Univ. Tsukuba, Tsukuba, JPN)
資料名:
Japanese Journal of Clinical Oncology
(Japanese Journal of Clinical Oncology)
巻:
40
号:
3
ページ:
194-202
発行年:
2010年03月
JST資料番号:
W2222A
ISSN:
0368-2811
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)